Skip to main content

Introduction to the Experimental Designs: Basic Fundamentals

  • Chapter
  • First Online:
Design of Experiments for Pharmaceutical Product Development

Abstract

The pharmaceutical drug products and process optimization with the help of traditional approaches are not new and for decades it has been performed with the help of one variable at a time (OVAT) approach. Although such shotgun approach has yielded the requirement and served the purpose to provide optimized solutions, yet achieving the true optimum is not guaranteed. Moreover, traditional approaches require extensive utilization of time, energy, and efforts to plug the errors and to rectify the problem. The approach of systematic optimization using design of experiments (DoE) principles is considered as highly satisfactory for providing the best solutions by establishing the relationship between the factors and responses. Such approach has yielded satisfactory outcomes with respect to its applicability for diverse pharmaceutical product and process optimization. The present chapter endeavors to provide an account on the basic principles and fundamentals of experimental design and their applications in drug product development.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Svenson S (2004) Carrier-based drug delivery. American Chemical Society, New York

    Book  Google Scholar 

  2. Beg S, Hasnain MS (2019) Pharmaceutical quality by design: principles and applications. Academic Press, New York

    Google Scholar 

  3. Beg S, Hasnain MS, Rahman M, Swain S (2019) In: Beg S, Hasnain MS (eds) Pharmaceutical quality by design. Academic Press, Cambridge, MA, pp 1–17

    Google Scholar 

  4. Beg S, Rahman M, Robaian MA, Alruwaili NK, Imam SS, Panda SK (2020) Pharmaceutical drug product development and process optimization: effective use of quality by design. CRC Press, New York

    Book  Google Scholar 

  5. Beg S, Rahman M, Swain S (2020) Quality by design applications in pharmaceutical product development. Pharma Focus Asia, pp. 1–5

    Google Scholar 

  6. Beg S, Rahman M, Kohli K (2019) Quality-by-design approach as a systematic tool for the development of nanopharmaceutical products. Drug Discov Today 24(3):717–725

    Article  PubMed  CAS  Google Scholar 

  7. Beg S, Rahman M, Panda SS (2017) Pharmaceutical QbD: omnipresence in the product development lifecycle. Eur Pharm Rev 22(1):58–64

    Google Scholar 

  8. Beg S, Swain S, Rahman M, Hasnain MS, Imam SS (2019) In: Beg S, Hasnain MS (eds) Pharmaceutical quality by design. Academic Press, New York, pp 43–64

    Chapter  Google Scholar 

  9. Singh B, Raza K, Beg S (2013) Developing “optimized” drug products employing “designed” experiments. Chem Ind Dig 23:70–76

    Google Scholar 

  10. Singh B, Sharma T, Saini S, Kaur R, Jain A, Raza K, Beg S (2020) Systematic development of drug nanocargos using formulation by design (FbD): an updated overview. Crit Rev Ther Drug Carrier Syst 37(3):226–269

    Article  Google Scholar 

  11. Singh B, Kumar R, Ahuja N (2005) Optimizing drug delivery systems using systematic “design of experiments.” part I: fundamental aspects. Crit Rev Ther Drug Carrier Syst 22(1):27–105

    Article  PubMed  CAS  Google Scholar 

  12. Singh B, Beg S (2015) Attaining product development excellence and federal compliance employing quality by design (QbD) paradigms. Pharm Rev 13(9):35–44

    Google Scholar 

  13. Singh B, Beg S (2013) Quality by design in product development life cycle. Chron Pharmabiz 22:72–79

    Google Scholar 

  14. Plackett RL, Burman JP (1946) The design of optimum multifactorial experiments. Biometrica 33:305–325

    Article  Google Scholar 

  15. Box GEP, Wilson KB (1951) On the experimental attainment of optimum conditions. J Royal Stat Soc Ser B 13:1–45

    Google Scholar 

  16. Scheffe H (1958) Experiments with mixtures. J R Stat Soc Ser B 20:344–360

    Google Scholar 

  17. Marlowe E, Shangraw RF (1967) Dissolution of sodium salicylate from tablet matrices prepared by wet granulation and direct compression. J Pharm Sci 56:498–504

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Beg, S., Swain, S. (2021). Introduction to the Experimental Designs: Basic Fundamentals. In: Beg, S. (eds) Design of Experiments for Pharmaceutical Product Development. Springer, Singapore. https://doi.org/10.1007/978-981-33-4717-5_1

Download citation

Publish with us

Policies and ethics